Rogier C. Buijsman

Oss, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination.

Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination.

Journal: Frontiers in oncology

Published: June 12, 2024

Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies.

Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies.

Journal: Neuro-oncology advances

Published: July 17, 2023

Minifragment plating of the fibula in unstable ankle fractures.

Minifragment plating of the fibula in unstable ankle fractures.

Journal: Archives of orthopaedic and trauma surgery

Published: November 22, 2021

LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.

LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.

Journal: Journal of hepatology

Published: October 06, 2021

Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.

Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.

Journal: Frontiers in immunology

Published: September 23, 2020

Pharmacological validation of TDO as a target for Parkinson's disease.

Pharmacological validation of TDO as a target for Parkinson's disease.

Journal: The FEBS journal

Published: September 11, 2020

Mapping Arginase Expression with 18F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids.

Mapping Arginase Expression with 18F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 11, 2020

High-Throughput Fluorescence-Based Activity Assay for Arginase-1.

High-Throughput Fluorescence-Based Activity Assay for Arginase-1.

Journal: SLAS discovery : advancing life sciences R & D

Published: May 19, 2020

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites.

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites.

Journal: Oncotarget

Published: April 08, 2020

Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158.

Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158.

Journal: Journal of structural biology: X

Published: October 19, 2019

Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017.

Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017.

Journal: Molecular cancer therapeutics

Published: August 03, 2018

Design, Synthesis, and Biological Evaluation of Novel Type I1/2 p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine.

Design, Synthesis, and Biological Evaluation of Novel Type I1/2 p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine.

Journal: Journal of medicinal chemistry

Published: August 24, 2017

Showing 1-12 of 27

Last Updated: 09/26/2026